290 related articles for article (PubMed ID: 33256914)
1. Modulating NK cell metabolism for cancer immunotherapy.
Terrén I; Orrantia A; Vitallé J; Astarloa-Pando G; Zenarruzabeitia O; Borrego F
Semin Hematol; 2020 Oct; 57(4):213-224. PubMed ID: 33256914
[TBL] [Abstract][Full Text] [Related]
2. NK Cell Metabolism and Tumor Microenvironment.
Terrén I; Orrantia A; Vitallé J; Zenarruzabeitia O; Borrego F
Front Immunol; 2019; 10():2278. PubMed ID: 31616440
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological targeting of natural killer cells for cancer immunotherapy.
Miyazato K; Hayakawa Y
Cancer Sci; 2020 Jun; 111(6):1869-1875. PubMed ID: 32301190
[TBL] [Abstract][Full Text] [Related]
4. Purinergic targeting enhances immunotherapy of CD73
Wang J; Lupo KB; Chambers AM; Matosevic S
J Immunother Cancer; 2018 Dec; 6(1):136. PubMed ID: 30514403
[TBL] [Abstract][Full Text] [Related]
5. Natural killer (NK) cell-based immunotherapies and the many faces of NK cell memory: A look into how nanoparticles enhance NK cell activity.
Mikelez-Alonso I; Magadán S; González-Fernández Á; Borrego F
Adv Drug Deliv Rev; 2021 Sep; 176():113860. PubMed ID: 34237404
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of NK cell dysfunction in the tumor microenvironment and current clinical approaches to harness NK cell potential for immunotherapy.
Devillier R; Chrétien AS; Pagliardini T; Salem N; Blaise D; Olive D
J Leukoc Biol; 2021 Jun; 109(6):1071-1088. PubMed ID: 32991746
[TBL] [Abstract][Full Text] [Related]
7. Current progress in cancer immunotherapy based on natural killer cells.
Bagheri Y; Barati A; Aghebati-Maleki A; Aghebati-Maleki L; Yousefi M
Cell Biol Int; 2021 Jan; 45(1):2-17. PubMed ID: 32910474
[TBL] [Abstract][Full Text] [Related]
8. Functional and metabolic targeting of natural killer cells to solid tumors.
Wang J; Matosevic S
Cell Oncol (Dordr); 2020 Aug; 43(4):577-600. PubMed ID: 32488848
[TBL] [Abstract][Full Text] [Related]
9. Enhancing a Natural Killer: Modification of NK Cells for Cancer Immunotherapy.
Islam R; Pupovac A; Evtimov V; Boyd N; Shu R; Boyd R; Trounson A
Cells; 2021 Apr; 10(5):. PubMed ID: 33946954
[TBL] [Abstract][Full Text] [Related]
10. NK cell metabolism.
Gardiner CM
J Leukoc Biol; 2019 Jun; 105(6):1235-1242. PubMed ID: 30676653
[TBL] [Abstract][Full Text] [Related]
11. The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies.
Bald T; Krummel MF; Smyth MJ; Barry KC
Nat Immunol; 2020 Aug; 21(8):835-847. PubMed ID: 32690952
[TBL] [Abstract][Full Text] [Related]
12. Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment.
Moinuddin A; Poznanski SM; Portillo AL; Monteiro JK; Ashkar AA
Immunol Rev; 2024 May; 323(1):19-39. PubMed ID: 38459782
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cell engineering - a new hope for cancer immunotherapy.
Lin CY; Gobius I; Souza-Fonseca-Guimaraes F
Semin Hematol; 2020 Oct; 57(4):194-200. PubMed ID: 33256912
[TBL] [Abstract][Full Text] [Related]
14. Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies.
Matosevic S
J Immunol Res; 2018; 2018():4054815. PubMed ID: 30306093
[TBL] [Abstract][Full Text] [Related]
15. Delivery technologies to engineer natural killer cells for cancer immunotherapy.
El-Mayta R; Zhang Z; Hamilton AG; Mitchell MJ
Cancer Gene Ther; 2021 Sep; 28(9):947-959. PubMed ID: 33888870
[TBL] [Abstract][Full Text] [Related]
16. Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities.
Hu W; Wang G; Huang D; Sui M; Xu Y
Front Immunol; 2019; 10():1205. PubMed ID: 31214177
[TBL] [Abstract][Full Text] [Related]
17. Designing multivalent proteins based on natural killer cell receptors and their ligands as immunotherapy for cancer.
Smits NC; Coupet TA; Godbersen C; Sentman CL
Expert Opin Biol Ther; 2016 Sep; 16(9):1105-12. PubMed ID: 27248342
[TBL] [Abstract][Full Text] [Related]
18. Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy.
Hu Y; Tian ZG; Zhang C
Acta Pharmacol Sin; 2018 Feb; 39(2):167-176. PubMed ID: 28880014
[TBL] [Abstract][Full Text] [Related]
19. Leveraging natural killer cells for cancer immunotherapy.
Grossenbacher SK; Aguilar EG; Murphy WJ
Immunotherapy; 2017 May; 9(6):487-497. PubMed ID: 28472904
[TBL] [Abstract][Full Text] [Related]
20. Immunometabolism and natural killer cell responses.
O'Brien KL; Finlay DK
Nat Rev Immunol; 2019 May; 19(5):282-290. PubMed ID: 30808985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
